SEC 13F Intelligence

Managers / Q3 2025 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$344M
Q3 2025
Positions
44
Filings on Record
30
2019–present window
Filed
Oct 23, 2025
original filing

Summary

Sivik Global Healthcare LLC reported $344M in U.S.-listed holdings across 44 positions for Q3 2025.

Its largest position, XBI, represents 7.3% of the portfolio.

Compared with Q2 2025, the fund opened 18 new positions and exited 20.

Portfolio Metrics

Turnover
+55.5%
vs prior filed quarter
Top-10 Concentration
+25.1%
share of reported value
Largest Position
+7.3%
Spdr S P Biotech Etf
New / Exited
18 / 20
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 45.8%Other: 45.2%ETP: 7.3%ADR: 1.7%
  • Common Stock · 45.8% · $157M
  • Other · 45.2% · $155M
  • ETP · 7.3% · $25M
  • ADR · 1.7% · $6M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PUT - SPY 100 @ 645 EXP 10/31/2025NEW+300300+$20M$20M
PUT - SPY 100 @ 659 EXP 10/31/2025NEW+250250+$17M$17M
PUT - SPY 100 @ 660 EXP 10/31/2025NEW+250250+$17M$17M
PUT - SPY 100 @ 658 EXP 10/31/2025NEW+250250+$17M$17M
PUT - SPY 100 @ 639 EXP 10/31/2025NEW+250250+$17M$17M
PUT - SPY 100 @ 659 EXP 11/21/2025NEW+250250+$17M$17M
PUT - SPY 100 @ 635 EXP 10/31/2025NEW+250250+$17M$17M
PUT - SPY 100 @ 660 EXP 11/21/2025NEW+250250+$17M$17M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2025

35 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBISPDR S&P BIOTECH ETFhistory →S&P BIOTECH7.29%$25M250.0K
2LLYELI LILLY & COhistory →COM2.22%$8M10.0K
3HCAHCA HEALTHCARE INChistory →COM2.11%$7M17.0K
4THCTENET HEALTHCAREhistory →COM NEW2.07%$7M35.0K
5DHRDANAHER CORPhistory →COM2.02%$7M35.0K
6BSXBOSTON SCIENTIFIC CORPORATIONhistory →COM1.99%$7M70.0K
7TMOTHERMO FISHER SCIENTIFIC INC.history →COM1.98%$7M14.0K
8HUMHUMANA INC.history →COM1.89%$7M25.0K
9CORCENCORA INChistory →COM1.82%$6M20.0K
10CAHCARDINAL HEALTHhistory →COM1.71%$6M37.5K
11ISRGINTUITIVE SURGhistory →COM NEW1.69%$6M13.0K
12SNNSMITH & NEPHEWhistory →SPDN ADR NEW1.69%$6M160.0K
13UHSUNIV HEALTH SVChistory →CLASS B1.67%$6M28.0K
14MDTMEDTRONIC INChistory →SHS1.66%$6M60.0K
15VRTXVERTEX PHARMACEUTICALS INC.history →COM1.60%$5M14.0K
16MCKMCKESSON CORPhistory →COM1.57%$5M7.0K
17ABTABBOTT LABShistory →COM1.46%$5M37.5K
18SYKSTRYKER CORPhistory →COM1.40%$5M13.0K
19SGRYSURGERY PARTNERS INChistory →COM1.39%$5M220.0K
20JNJJOHNSON&JOHNSONhistory →COM1.35%$5M25.0K
21ABBVABBVIE INChistory →COM1.35%$5M20.0K
22EHCENCOMPASS HEALTH CORPhistory →COM1.29%$4M35.0K
23AAGILENT TECHNOLOGIES INChistory →COM1.23%$4M33.0K
24UNHUNITEDHEALTH GRPhistory →COM1.21%$4M12.0K
25CICIGNA GROUP/THEhistory →COM1.17%$4M14.0K
26ZBHZIMMER BIOMET HOLDINGS INChistory →COM1.15%$4M40.0K
27WSTWEST PHARMACEUTICAL SERVICES INChistory →COM1.14%$4M15.0K
28DGXQUEST DIAGNOSTIC INChistory →COM1.11%$4M20.0K
29RGENREPLIGEN CORPhistory →COM1.07%$4M27.5K
30BIOBIO-RAD LABS ACL A0.90%$3M11.0K
31LHLABCORP HOLDINGS INCCOM SHS0.84%$3M10.0K
32S24SELECT MEDICAL HOLDINGS CORPCOM0.65%$2M175.0K
33STEVANATO GROUP SPACOM0.64%$2M85.0K
34BRKRBRUKER CORPORATIONCOM0.57%$2M60.0K
35GEHCGE HEALTHCARE TECHNOLOGYCOMMON STOCK0.55%$2M25.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.